Table 2.
Mean values (X ± SD) of Th1/Th2 cytokine ratios for control subjects, DTC patient before and 7 days after 131-I therapy
| Th1/Th2 | Control subjects | DTC patients before 131-I therapy | DTC patients 7 days after 131-I therapy |
|---|---|---|---|
| X ± SD | X ± SD | X ± SD | |
| IFN-γ/IL-4 | 46.2 ± 46.4 | 66.6 ± 60.4 | 47.9 ± 53.6 |
| IFN-γ/IL-5 | 24.0 ± 21.9 | 17.9 ± 14.0 | 18.2 ± 21.3 |
| IFN-γ/IL-10 | 29.4 ± 22.8 | 43.4 ± 31.3 | 59.5 ± 39.2 |
| TNF-α/IL-4 | 0.67 ± 0.63 | 3.98 ± 8.66 | 0.84 ± 0.79 |
| TNF-α/IL-5 | 0.34 ± 0.27 | 0.45 ± 0.52 | 0.56 ± 1.01 |
| TNF-α/IL-10 | 0.48 ± 0.50 | 0.77 ± 0.54 | 0.64 ± 0.29 |